Opioid Manufacturer Purdue Pharma
Outcome
OIG enforcement action against Opioid Manufacturer Purdue Pharma for kickbacks, controlled substance.
Details
Opioid Manufacturer Purdue Pharma — OIG Enforcement (2026)
OIG took enforcement action against Opioid Manufacturer Purdue Pharma in NJ in 2026 involving kickbacks, controlled substance violations in the Independent Pharmacies sector.
Violation types: Kickbacks, Controlled Substance
Entity type: Healthcare Provider
Penalty type: Criminal
Location: NJ
Source: Opioid Manufacturer Purdue Pharma Pleads Guilty to Fraud and Kickback Conspiracies
How Crucible Prevents This
Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works